CONCORDBIO.BOCONCORDBIO.BOBSE

Revenue (LTM)

$12.0B

+18.0% YoY

Net Income (LTM)

$3.7B

+20.6% YoY

Free Cash Flow

$1.4B

Revenue CAGR (5Y)

+18.6%

Marginsdeclining

FCF$1.4B

Profitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	6,169	7,129↑15.6%	8,532↑19.7%	10,169↑19.2%	12,001↑18.0%
Gross Profit	5,000	5,410↑8.2%	6,611↑22.2%	6,672↑0.9%	7,684↑15.2%
Operating Income	4,300	4,162↓3.2%	5,180↑24.4%	5,212↑0.6%	6,020↑15.5%
Net Income	2,349	1,749↓25.5%	2,401↑37.2%	3,081↑28.3%	3,716↑20.6%
EBITDA	3,287	2,778↓15.5%	3,527↑26.9%	4,386↑24.4%	5,127↑16.9%
EPS Diluted	22.45	16.72↓25.5%	22.95↑37.3%	29.45↑28.3%	35.52↑20.6%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	51	7↓87.0%	35↑424.6%	151↑332.8%	12↓92.2%
Total Current Assets	6,071	6,327↑4.2%	7,277↑15.0%	8,962↑23.2%	11,352↑26.7%
Total Assets	11,825	13,128↑11.0%	15,140↑15.3%	17,007↑12.3%	20,343↑19.6%
Total Current Liabilities	1,057	1,552↑46.7%	1,918↑23.6%	1,422↓25.9%	1,841↑29.5%
Total Liabilities	1,832	2,096↑14.4%	2,240↑6.9%	1,741↓22.3%	2,215↑27.3%
Total Equity	9,994	11,032↑10.4%	12,900↑16.9%	15,266↑18.3%	18,127↑18.7%
Total Debt	893	625↓30.0%	315↓49.5%	97↓69.1%	30↓69.5%
Net Debt	841	618↓26.5%	280↓54.6%	-54↓119.3%	18↑133.1%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	1,668	2,075↑24.4%	2,460↑18.6%	2,655↑7.9%	2,474↓6.8%
Capital Expenditure	-2,042	-1,555↑23.8%	-1,451↑6.7%	-857↑40.9%	-1,112↓29.7%
Free Cash Flow	-374	520↑239.1%	1,009↑94.2%	1,798↑78.1%	1,362↓24.2%
Stock-Based Comp	0	0	0	0	0
Net Change in Cash	27	-45↓263.6%	28↑163.3%	116↑311.1%	-196↓268.6%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance